These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of super enhancer-associated key genes for prognosis of germinal center B-cell type diffuse large B-cell lymphoma by integrated analysis. Li X; Duan Y; Hao Y BMC Med Genomics; 2021 Mar; 14(1):69. PubMed ID: 33663517 [TBL] [Abstract][Full Text] [Related]
7. Mutational landscape of high-grade B-cell lymphoma with Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of 'double-hit' and 'double-expression' lymphomas. Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842 [TBL] [Abstract][Full Text] [Related]
9. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Hilton LK; Tang J; Ben-Neriah S; Alcaide M; Jiang A; Grande BM; Rushton CK; Boyle M; Meissner B; Scott DW; Morin RD Blood; 2019 Oct; 134(18):1528-1532. PubMed ID: 31527075 [TBL] [Abstract][Full Text] [Related]
10. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G; J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305 [TBL] [Abstract][Full Text] [Related]
11. Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases. Pina-Oviedo S; Bellamy WT; Gokden M Ann Diagn Pathol; 2020 Oct; 48():151610. PubMed ID: 32889391 [TBL] [Abstract][Full Text] [Related]
12. A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements. Jarosova M; Kriegova E; Schneiderova P; Fillerova R; Prochazka V; Mikesova M; Flodr P; Indrak K; Papajik T Pathol Oncol Res; 2016 Apr; 22(2):233-43. PubMed ID: 26319027 [TBL] [Abstract][Full Text] [Related]
13. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Xu-Monette ZY; Dabaja BS; Wang X; Tu M; Manyam GC; Tzankov A; Xia Y; Zhang L; Sun R; Visco C; Dybkaer K; Yin L; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Zhao X; Winter JN; Piris MA; McDonnell TJ; Miranda RN; Li Y; Medeiros LJ; Young KH Mod Pathol; 2015 Dec; 28(12):1555-73. PubMed ID: 26541272 [TBL] [Abstract][Full Text] [Related]
14. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type. El Jamal SM; Grada Z; El Dinali MH; Zhou H; Hassan SY; Saad AG; Gibson B; Zhou X; Abulsayen HA; Khadra HS; Friedman J; Shalaby H; Kadi A; Megahed M; Emberesh M; Teruya-Feldstein J; Firpo-Betancourt A; Haikel Y; Fraig M; Hassan M Lab Invest; 2019 Apr; 99(4):539-550. PubMed ID: 30446717 [TBL] [Abstract][Full Text] [Related]
15. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry. Lešková K; Szépe P; Balhárek T; Barthová M; Janáková Ľ; Farkašová A; Plank L Neoplasma; 2022 Jul; 69(4):957-964. PubMed ID: 35652622 [TBL] [Abstract][Full Text] [Related]
16. ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma. Sartori G; Napoli S; Cascione L; Chung EYL; Priebe V; Arribas AJ; Mensah AA; Dall'Angelo M; Falzarano C; Barnabei L; Forcato M; Rinaldi A; Bicciato S; Thome M; Bertoni F J Exp Clin Cancer Res; 2021 Nov; 40(1):357. PubMed ID: 34763718 [TBL] [Abstract][Full Text] [Related]
17. Non-germinal center B-cell subtype of pediatric diffuse large B-cell lymphoma in Japan: A retrospective cohort study. Hori D; Kobayashi R; Nakazawa A; Iwafuchi H; Klapper W; Osumi T; Ohk K; Sekimizu M Pediatr Blood Cancer; 2023 May; 70(5):e30279. PubMed ID: 36860130 [TBL] [Abstract][Full Text] [Related]
18. [Immunophenotyping and molecular genetic analysis of diffuse large B-cell lymphoma]. Han YS; Xue YQ; Yang HY; Zhang J; Pan JL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):143-7. PubMed ID: 23568722 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases]. Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172 [No Abstract] [Full Text] [Related]
20. Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma. Bellas C; García D; Vicente Y; Kilany L; Abraira V; Navarro B; Provencio M; Martín P PLoS One; 2014; 9(6):e98169. PubMed ID: 24887414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]